Activation Capital Member Tympanogen Plans to Bring First Commercial Product to Market
Tympanogen, a medical device company and member of Activation Capital, is working to go to market with a gel patch to repair perforated eardrums. The
Tympanogen, a medical device company and member of Activation Capital, is working to go to market with a gel patch to repair perforated eardrums. The
A capacity crowd filled Bio+Tech Center as members of the life sciences community from across the Richmond-Petersburg region came together for the most recent Biotech
Activation Capital began its “Science Rocks” speaker series with an entertaining and inspiring evening featuring Dr. Raven Baxter, aka, “Dr. Raven the Science Maven.” A
The Central Virginia region is home to an amazing network of biotech, pharma, medical device, healthcare and life science professionals. We also happen to live
The Central Virginia region is continuing to expand its BioHealth entrepreneurship and community development activities thanks to a multimillion-dollar award from the Commonwealth’s GO Virginia economic development program and close partnerships between the Virginia Biotech Research Park Authority (VBRPA), its nonprofit affiliate (Activation Capital), Virginia Commonwealth University, Richmond’s GROW Capital Jobs, and area economic development organizations.
Richmond, VA – February 18, 2025 – Activation Capital announced today that Jim Pannucci, PhD, Vice President of Entrepreneurship and Ecosystem Development, has been honored as BioBuzz’s 2024
Governor Glenn Youngkin has appointed Paul Nolde to the board of the Virginia Biotechnology Research Partnership Authority. As a political subdivision of the Commonwealth, the Authority Board works to grow the regional innovation economy.
The inaugural Frontier BioHealth Showcase, hosted by Activation Capital, brought together 10 high-potential life science startups, regional leaders, and national investors at Main Street Station on November 20, 2024.
Activation Capital, an innovation ecosystem development organization, today announced Governor Glenn Youngkin’s appointment of Brian Anderson and Barrett E. Clark to the board of the Virginia Biotechnology Research Partnership Authority (dba Activation Capital).
Ten innovative life sciences and healthtech companies enter 16-week accelerator.